Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $150.48 USD
Change Today +1.40 / 0.94%
Volume 133.5K
CHE On Other Exchanges
Symbol
Exchange
New York
As of 8:04 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for chemed corp (CHE)

Although debt as a percent of total capital decreased at Chemed Corp. over the last fiscal year to 24.63%, it is still in-line with the Healthcare Providers and Services industry's norm. Additionally, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are among the industry's worst, and weakening, with 27.12 days worth of sales outstanding. This implies that revenues are not being collected in an efficient manner. Last, Chemed Corp. is among the least efficient in its industry at managing inventories, with 2.27 days of its Cost of Goods Sold tied up in Inventories.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 31
2012
Reclassified
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Assets    
Cash and Equivalents38.169.584.414.1
TOTAL CASH AND SHORT TERM INVESTMENTS38.169.584.414.1
Accounts Receivable77.993.391.8124.6
TOTAL RECEIVABLES77.993.391.8124.6
Inventory8.77.16.76.2
Prepaid Expenses11.411.417.811.5
Deferred Tax Assets, Current12.513.720.315.4
Other Current Assets2.12.63.72.8
TOTAL CURRENT ASSETS150.8197.7224.7174.6
Gross Property Plant and Equipment184.9209.4224.4239.5
Accumulated Depreciation-117.3-131.5-143.6-144.7
NET PROPERTY PLANT AND EQUIPMENT67.677.880.894.8
Goodwill460.6465.8466.9466.7
Deferred Tax Assets, Long Term0.2------
Other Intangibles73.771.368.866.5
Other Long-Term Assets43.247.052.757.3
TOTAL ASSETS795.9859.6893.7859.9
    
LIABILITIES & EQUITY    
Accounts Payable37.948.541.846.8
Accrued Expenses78.587.6113.492.3
Short-Term Borrowings10.3------
Current Portion of Long-Term Debt/Capital Lease----183.66.3
Current Income Taxes Payable0.14.90.15.8
Other Current Liabilities, Total18.615.825.224.4
TOTAL CURRENT LIABILITIES145.4156.8364.0175.6
Long-Term Debt166.8174.9--141.3
Deferred Tax Liability Non-Current29.527.727.329.9
Other Non-Current Liabilities40.647.053.561.8
TOTAL LIABILITIES382.2406.3444.8408.6
Common Stock30.931.632.233.3
Additional Paid in Capital398.1437.4481.0538.8
Retained Earnings546.8623.0686.1771.2
Treasury Stock-564.1-640.7-752.6-894.3
Comprehensive Income and Other2.02.02.22.3
TOTAL COMMON EQUITY413.7453.3448.9451.4
TOTAL EQUITY413.7453.3448.9451.4
TOTAL LIABILITIES AND EQUITY795.9859.6893.7859.9
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHE:US $150.48 USD +1.40

CHE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amedisys Inc $47.44 USD +2.56
Integra LifeSciences Holdings Corp $62.04 USD -2.04
Masimo Corp $41.78 USD +0.73
STERIS Corp $67.80 USD -0.81
West Pharmaceutical Services Inc $60.31 USD +0.47
View Industry Companies
 

Industry Analysis

CHE

Industry Average

Valuation CHE Industry Range
Price/Earnings 24.6x
Price/Sales 1.7x
Price/Book 5.3x
Price/Cash Flow 18.0x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMED CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.